| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 2101651-50-5 | 1-[(3-Fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide | C14H12FN5 |
| 2101700-15-4 | Pirtobrutinib | C22H21F4N5O3 |
| 2101947-36-6 | 2,3-Dihydro-3-[(4-methyl-1-piperazinyl)phenylmethylene]-2-oxo-1H-indole-6-carboxylic acid methyl ester | C22H23N3O3 |
| 2102090-15-1 | (+)-alpha-Dihydrotetrabenazine D-(+)-Camphorsulfonate | C19H29NO3.C10H16O4S |
| 2102162-79-6 | (3Z)-2,3-Dihydro-2-oxo-3-(phenyl-1-piperidinylmethylene)-1H-indole-6-carboxylic acid methyl ester | C22H22N2O3 |
| 2102196-57-4 | 2-[[4-[(2'-Chloro[1,1'-biphenyl]-3-yl)methoxy]phenyl]sulfonyl]acetic acid | C21H17ClO5S |
| 2102517-30-4 | Potassium 2,2-difluoro-4,5-dioxo-1,3,2-dioxaborolan-2-uide | C2BF2KO4 |
| 2102544-35-2 | JackiePhos Pd G3 | C52H51F12NO5PPdS- |
| 2102609-59-4 | Escitalopram EP Impurity F | C14H18N2O2 |
| 2106868-09-9 | (3aS,4S,6aR)-Hexahydro-N-[(3beta)-3-hydroxychol-5-en-24-yl]-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanamide | C34H55N3O3S |
| 2106868-12-4 | (3beta)-24-Azidochol-5-en-3-ol | C24H39N3O |
| 2106888-81-5 | 4,4,5,5-Tetramethyl-2-(spiro[fluorene-9,9'-xanthen]-3'-yl)-1,3,2-dioxaborolane | C31H27BO3 |
| 2108550-78-1 | 4-Hydrazinyl-1-piperidinecarboxylic acid 1,1-dimethylethyl ester ethanedioate (1:1) | C10H21N3O2.C2H2O4 |
| 2108968-20-1 | Venlafaxine EP Impurity G | C17H28ClNO |
| 2115779-15-0 | Pantoprazole EP Impurity E | C32H28F4N6O8S2 |
| 2116542-19-7 | 7-[4-[(2-oxo-1H-quinolin-7-yl)oxy]butoxy]-1H-quinolin-2-one | C22H20N2O4 |
| 2117346-85-5 | Nicotinamide-13C3,15N | C313C3H6N15NO |
| 2117703-26-9 | Dacomitinib Impurity SFAJ | C15H12F2N4O |
| 2118954-10-0 | (3-exo)-9-Methyl-9-azabicyclo[3.3.1]nonan-3-amine hydrochloride (1:2) | C9H18N2.2(HCl) |
| 2118959-55-8 | Ephos | C36H55OP |
| 2119574-93-3 | 5,6,7,8-Tetrahydro-4H-thiazolo[4,5-d]azepin-2-amine hydrochloride | C7H11N3S.HCl |
| 2119588-41-7 | (S)-2-aminopropanenitrile 4-methylbenzenesulfonate | C10H14N2O3S |
| 2119689-75-5 | Dacomitinib Impurity SFXJ | C15H10F2N4O3 |
| 2124272-05-3 | Rosuvastatin Impurity 35 | C13H24O5 |
| 2124275-54-1 | Rosuvastatin Impurity 30 | C13H22O5 |
| 2125472-55-9 | (2-Chloro-5-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)phenyl)(4-(((S)-tetrahydrofuran-3-yl)oxy)phenyl)methanone | C23H25ClO8 |
| 2125473-29-0 | 2-Chloro-4-(3-chlorophenyl)-6-phenyl-1,3,5-triazine | C15H9Cl2N3 |
| 2126088-17-1 | N-[(2S)-2-Azetidinylmethyl]carbamic acid 1,1-dimethylethyl ester hydrochloride | C9H18N2O2.HCl |
| 2126177-46-4 | [4-(Trifluoromethyl)piperidin-4-yl]methanol hydrochloride | C7H13ClF3NO |
| 2127387-65-7 | Bempedoic acid impurity 16 | C19H34O4 |
| 2128291-05-2 | 4-Bromobenzo[1,2-b:3,4-b']bisbenzofuran | C18H9BrO2 |
| 2130840-90-1 | Levofloxacin-007-S | C20H25FN4O4 |
| 2130840-92-3 | Levofloxacin Impurity 8-S | C20H24FN3O4 |
| 2131025-93-7 | Eltrombopag Olamine impurity 02 | C32H28N4O4 |
| 2132949-19-8 | 2-[[4-Chloro-2-(trifluoromethyl)phenyl]methyl]-1H-indole-5-carboxylic acid methyl ester | C18H13ClF3NO2 |
| 2132978-44-8 | EPhos Pd G4 | C50H70NO4PPdS |
| 2133360-04-8 | Pomalidomide-PEG1-azide | C17H16N6O6 |
| 2133460-43-0 | (3S,5R,6R)-Bupropion Impurity | C12H14ClNO3S |
| 2134109-10-5 | Ibrutinib Impurity 17 | C16H18N6O |
| 2135576-73-5 | Vortioxetine Impurity 24 | C19H22N2OS |
| 2135600-87-0 | (5-Fluoro-2,3-dihydrobenzofuran-4-yl)methanamine hydrochloride | C9H11ClFNO |
| 2136287-59-5 | Methyl 3-(benzyloxy)-1-((tert-butoxycarbonyl)amino)-4-oxo-1,4-dihydropyridine-2-carboxylate | C19H22N2O6 |
| 2136287-61-9 | tert-Butyl (3-(benzyloxy)-2-((2-(2,2-dimethoxyethoxy)ethyl)carbamoyl)-4-oxopyridin-1(4H)-yl)carbamate | C24H33N3O8 |
| 2136287-65-3 | 3,4-Difluoro-2-((phenylthio)methyl)benzoic acid | C14H10F2O2S |
| 2136287-66-4 | 7,8-Difluoro-dibenzo[b,e]thiepin-11(6H)-one | C14H8F2OS |
| 2137047-43-7 | 3-(2,3-Difluoro-4-methoxyphenyl)-2,5-dimethyl-7-(trifluoromethyl)-pyrazolo[1,5-a]pyrimidine | C16H12F5N3O |
| 2137418-13-2 | (2S,3R,4R,5S,6R)-2-(4-Chloro-3-(hydroxy(4-(((S)-tetrahydrofuran- 3-yl)oxy)phenyl)methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H- pyran-3,4,5-triol | C23H27ClO8 |
| 2137722-14-4 | Vortioxetine impurity 04 | C18H23ClN2S |
| 2137744-33-1 | N-[1-[7-(2-Butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]formamide | C26H28N8O3 |
| 2137793-92-9 | Vortioxetine Impurity 11 | C18H23ClN2S |